Live Stock Vaccine Market Outlook for 2024 to 2034

The livestock vaccine market is predicted to be valued at US$ 6.1 billion in 2024 and rise to US$ 11.2 billion by 2034. The market is expected to grow at a CAGR of 6.2% during the forecast period.

Key Market Drivers

With the objective of giving the animal a vaccine to stimulate the immune system to form antibodies for the upliftment of their well-being, there is a huge rise in the livestock vaccine market. Some factors are mentioned below-

  • The increasing demand for protein-rich diets, especially meat and dairy products, is leading to the need for healthy livestock populations and a surge in the demand for vaccines to prevent diseases.
  • Rise in the prevalence of diseases among livestock causes significant economic loss. Thus, vaccination is becoming a crucial preventive measure for controlling and managing diseases effectively.
  • With increasing government initiatives to eradicate livestock diseases, aiming to enhance food security and public health, demand for vaccination increasing.
  • Ongoing innovations in biotechnology and genetic engineering enhance the efficacy and convenience of vaccination, encouraging their adoption among livestock producers.
  • Livestock vaccines play a crucial role in preventing zoonotic diseases at their source, as there is an emphasis on the prevention of zoonotic diseases that can be transmitted between animals and humans.
  • Rapid expansion in the livestock industry in emerging markets is driven by urbanization, rising disposable incomes, and changing dietary preferences. This serves as an opportunity for vaccine manufacturers to meet the increasing demand for livestock vaccines.
  • With the globalization of trade in livestock and livestock products, vaccination plays a crucial role in mitigating this risk by ensuring the health and biosecurity of livestock populations.
Attributes Key Statistics
Live Stock Vaccine Market Value (2024) US$ 6.1 billion
Anticipated Market Value (2034) US$ 11.2 billion
Estimated Growth (2024 to 2034) 6.2 % CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Diverse Applications of Live Stock Vaccine

Despite the healthy growth of the livestock vaccine market in healthcare sectors, several factors are slowing down the market.

  • Livestock producers are increasingly seeking to ensure consistent livestock health to ensure a reliable supply of high-quality products for consumers.
  • In the livestock industry, there is a shift towards proactive and preventive healthcare practices, resulting in a preference for vaccination over curative treatments.
  • Vaccines are viewed as cost-effective, reliable, and environment-friendly means of disease prevention, which urges widespread adoption.
  • The surge in the sales of livestock vaccines to prevent outbreaks affecting livestock, producers prioritize disease control measures to protect their herds and mitigate losses.
  • During trade restrictions or disease-related trade bans, there is a heightened demand for livestock vaccines to ensure compliance with biosecurity regulations and maintain access to export markets. This results in increased sales and adoption of vaccines.
  • Continued investments in research and development drive innovation in the livestock vaccine market. New and improved vaccines enhance their popularity among livestock producers, compelling market growth and sales.

Challenges Impeding Growth in the Live Stock Vaccine Market

  • Strict regulatory requirements for vaccine approval and registration can delay market entry and increase development costs.
  • Limited awareness among livestock producers about the importance and benefits of vaccination can inhibit market growth.
  • Inadequate infrastructure and limited access to cold chain facilities in remote or rural areas can affect vaccine distribution and efficacy.
  • High upfront costs associated with implementing vaccination programs, including vaccine procurement, storage, and administration, can dissuade adoption, especially among small-scale farmers.
  • Perceived or actual issues related to vaccine efficacy, such as low effectiveness against certain strains of pathogens, can undermine confidence in vaccination programs.
  • Inadequate biosecurity measures on farms, such as poor sanitation practices and lack of quarantine protocols increases the risk of disease transmission and reduce the effectiveness of vaccination efforts.
  • Insufficient funding for research and development in veterinary vaccines may limit innovation and the development of new and improved vaccine formulations.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

Broader Spectrum Coverage of Inactivated Vaccine Aids in Market Development

Inactivate vaccines ensure quality assurance and validation, upsurging the global livestock vaccine market with a 6.0% CAGR through 2034.

Attributes Details
Top Type Inactivated
CAGR (2024 to 2034) 6.0%
  • Efficacy, safety, and regulatory compliance make inactivated vaccines top choice in the livestock vaccine market. These vaccines contain killed pathogens or antigens, making them suitable for a wide range of livestock species without the risk of causing disease.
  • Manufacturers prefer inactivated vaccines as they have a longer shelf life and do not require strict cold chain storage, facilitating distribution and administration in diverse geographical regions.
  • Inactivated vaccines possess established safety profiles and compatibility with breeding animals and young livestock, further contributing to their popularity among producers and veterinarians.

Large Market Size and Global Importance of Bovine Vaccine

Bovine vaccines are crucial in economic and productivity concerns, heightening the global livestock vaccine market by 5.8% CAGR from 2024 to 2034.

Attributes Details
Top Animal Type Bovine
CAGR (2024 to 2034) 5.8%
  • Enormous economic importance of cattle farming worldwide makes bovine vaccines a highly favorable choice in the livestock vaccine market.
  • Cattle contribute to a significant portion of the global livestock population and are essential for meat, dairy, and leather production. Farmers and producers maintain the health and productivity of their cattle herds for better outcomes.
  • Bovine vaccines are specifically designed to combat prevalent diseases such as bovine viral diarrhea (BVD), bovine respiratory syncytial virus (BRSV), and infectious bovine rhinotracheitis (IBR). These diseases significantly affect productivity and cause economic downtrend in industry.

Country-wise Insights

The section analyzes the global livestock vaccine market by country, including the United Kingdom, the United States, China, South Korea, and Japan.

The table presents the CAGR for each country, indicating the expected market growth through 2034.

Countries CAGR (2024 to 2034)
South Korea 8.0%
Japan 7.9%
United Kingdom 7.4%
China 6.8%
United States 6.4%

Expansion of the South Korea's Livestock Vaccine Market Due to Increased Disease Prevention Awareness

With growing demand for personalized medicine and advancements in precision healthcare, South Korea is well-positioned to capitalize on the opportunities presented by the expanding global livestock vaccine market with a CAGR of 8.0% from 2024 to 2034.

South Korea is investing in research and development to create innovative vaccine solutions to cater to the needs of the livestock sector. The market presents opportunities for collaborations with global vaccine manufacturers to introduce advanced technologies, expansion of vaccine production capabilities to meet both domestic and international demand, and the adoption of digital solutions for efficient vaccine distribution and administration.

South Korea's innovation in the field includes the development of novel vaccine delivery systems such as edible vaccines that offer convenience and improved efficacy. Future plans involve partnerships between public and private sectors to establish advance vaccine manufacturing facilities and enhance biosecurity measures to prevent disease outbreaks.

Market Expansion in Japan Driven by Increased Livestock Production

Japan is flourishing in the livestock vaccine market due to the country's growing emphasis on food safety, animal health, and sustainable agriculture. The market has a CAGR of 7.9%, which is expected to continue through 2034.

Japan is investing heavily in research and development, with a particular focus on improving the efficacy and safety of livestock vaccines. Collaboration between government agencies, academic institutions, and pharmaceutical companies is also on the rise, as they work together to create innovative vaccine solutions customized to meet the unique needs of the local livestock industry.

Notable organizations driving this growth include the National Institute of Animal Health and the Japan Livestock Technology Association, both actively engaged in vaccine research and development.

Emphasis on Technological Advancements Propelling Market Growth in the United Kingdom

The livestock vaccine market in the United Kingdom is projected to expand at a CAGR of 7.4% through 2034.

The United Kingdom is expanding with increased awareness of animal health and welfare. Growing Concerns about zoonotic diseases and government initiatives to support sustainable agriculture are uplifting the market growth. The United Kingdom is approaching this expansion by investing in research and development, fostering collaborations between academia and industry, and implementing regulatory measures to ensure the safety and efficacy of veterinary vaccines.

Famous centers such as the Pirbright Institute and the Roslin Institute play a crucial role in vaccine research and development, contributing to the expansion of the market. Upcoming projects like the United Kingdom Vaccine Manufacturing and Innovation Centre (VMIC) aim to strengthen the country's vaccine manufacturing capabilities and support the production of vaccines for livestock diseases.

Rising Demand and Modernization Soar the Livestock Vaccine Market in China

China is emerging as a key player in the livestock vaccine market. The market is projected to rise at a CAGR of 6.8% from 2024 to 2034. China is in a steady race to improve its veterinary healthcare sector.

Chinese government has made considerable efforts and investments in veterinary vaccines, prioritizing the health of livestock and food safety. These initiatives include research and development aimed at innovating vaccine formulations to tackle local disease challenges and production systems.

China has been actively promoting the use of vaccination programs among livestock producers through subsidies and educational campaigns, resulting in increased adoption rates. The demand for animal protein is also on the rise, along with the growth of the livestock industry leading to an escalating need for effective disease prevention measures in China.

Increasing Demand for Protein-Rich Diets and Government Support Drives the United States Market

Ongoing advancement and research in the United States soar market growth, with an expected CAGR of 6.4% until 2034.

The livestock vaccine market in the United States is expanding due to several factors. Innovative developments in veterinary vaccines, such as the introduction of novel formulations and delivery methods, have spurred growth by enhancing vaccine efficacy and safety. Research projects focused on improving disease prevention and management have contributed to market expansion, with initiatives aimed at addressing emerging livestock diseases and increasing vaccine accessibility.

Notable companies driving this growth include Zoetis, Merck Animal Health, and Elanco, which have a strong presence in the United States to develop cutting-edge vaccine solutions tailored to the needs of American livestock producers.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

Manufacturers and major companies are taking proactive measures to expand their market presence, as they are witnessing high demand in the livestock vaccine market. Companies such as Zoetis, Merck Animal Health, and Elanco are investing in research and development to create innovative vaccine formulations and delivery methods, which enhance the efficacy and safety of the vaccines.

With the growing global demand for protein-rich diets and increased awareness of animal health and welfare, there are significant opportunities for manufacturers to capitalize on the expanding livestock vaccine market. Some of the emerging trends in this market, such as personalized vaccination programs and the development of vaccines for emerging diseases, present promising avenues for growth and differentiation.

Recent Developments

  • On December 28, 2023, Indian Immunologicals (IIL), a biotechnology firm under the National Dairy Development Board (NDDB), initiated construction of its new vaccine manufacturing plant in Genome Valley, Hyderabad. The company had invested approximately Rs 700 crore in the facility.
  • On February 23, 2024, Bangladeshi Fisheries and Livestock Minister Abdur Rahman announced the government's intention to produce foot and mouth disease (FMD) vaccine locally in response to the rapid growth of the domestic FMD vaccine market.
  • On January 9, 2024, Zhengye Biotechnology (ZYBT), a livestock vaccine manufacturer that sells vaccines in China and other countries, filed for a $20M US IPO.
  • On July 28, 2023, the Yobe State Government procured 1.5 million doses of anthrax vaccine for livestock. The move aimed to mitigate the spread of anthrax disease among animals.

Key Companies in the Market

  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck Animal Health
  • Ceva, Elanco

Key Coverage in the Live Stock Vaccine Market Report

  • Detailed Study in Advances in Irradiated Livestock Vaccine Research
  • Analysis of the Animal Vaccine Industry
  • Vaccinations for the Beef Cattle Herd Demand Analysis
  • Market Analysis on Veterinary Immunization Products
  • Insights into the Types of Vaccines for Animals
  • Difference Between 7 in 1 Vaccine For Cattle and 3 in 1 Vaccine For Cattle

Market Segmentation

By Type:

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Animal Type:

  • Bovine
  • Swine/ Porcine
  • Poultry
  • Others

By Route of Administration:

  • Oral
  • Parenteral
  • Others

By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa (MEA)
  • Europe

Frequently Asked Questions

What is the Live Stock Vaccine Market Worth in 2024?

The livestock vaccine market is projected to be worth US$ 6.1 billion in 2024.

What is the Sales Forecast for Live Stock Vaccines through 2034?

The market is expected to reach US$ 11.2 billion by 2034.

At What Rate is the Live Stock Vaccine Market Expected to Grow?

The market is expected to grow at a CAGR of 6.2% from 2024 to 2034.

Who are the Key Manufacturers of the Livestock Vaccines?

Boehringer Ingelheim International GmbH, Virbac, Merck Animal Health, Ceva, and Elanco are among the major companies actively contributing to the growth of the global livestock vaccine market.

What Factor is Driving the Demand for Live Stock Vaccines?

Increasing demand for animal protein is accelerating the demand for livestock vaccines.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Manufacturer
            3.5.1.2. Mid-Level Participants (Traders)
            3.5.1.3. Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Distributors
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
    4.1. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis, 2019 to 2023
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Vials) Projections, 2024 to 2034
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Type, 2019 to 2023
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Type, 2024 to 2034
        5.3.1. Inactivated
        5.3.2. Live Attenuated
        5.3.3. Recombinant
        5.3.4. Others
    5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023
    5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Animal Type
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Animal Type, 2019 to 2023
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Animal Type, 2024 to 2034
        6.3.1. Bovine
        6.3.2. Swine/ Porcine
        6.3.3. Poultry
        6.3.4. Others
    6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2019 to 2023
    6.5. Absolute $ Opportunity Analysis By Animal Type, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Route of Administration, 2019 to 2023
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Route of Administration, 2024 to 2034
        7.3.1. Oral
        7.3.2. Parenteral
        7.3.3. Others
    7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023
    7.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Distribution Channel, 2019 to 2023
    8.3. Current and Future Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Distribution Channel, 2024 to 2034
        8.3.1. Veterinary Hospitals
        8.3.2. Veterinary Clinics
        8.3.3. Others
    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) & Volume (Vials) Analysis By Region, 2019 to 2023
    9.3. Current Market Size Value (US$ Million) & Volume (Vials) Analysis and Forecast By Region, 2024 to 2034
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Western Europe
        9.3.4. Eastern Europe
        9.3.5. South Asia and Pacific
        9.3.6. East Asia
        9.3.7. Middle East and Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    10.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        10.2.1. By Country
            10.2.1.1. USA
            10.2.1.2. Canada
        10.2.2. By Type
        10.2.3. By Animal Type
        10.2.4. By Route of Administration
        10.2.5. By Distribution Channel
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Type
        10.3.3. By Animal Type
        10.3.4. By Route of Administration
        10.3.5. By Distribution Channel
    10.4. Key Takeaways
11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    11.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        11.2.1. By Country
            11.2.1.1. Brazil
            11.2.1.2. Mexico
            11.2.1.3. Rest of Latin America
        11.2.2. By Type
        11.2.3. By Animal Type
        11.2.4. By Route of Administration
        11.2.5. By Distribution Channel
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Type
        11.3.3. By Animal Type
        11.3.4. By Route of Administration
        11.3.5. By Distribution Channel
    11.4. Key Takeaways
12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    12.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        12.2.1. By Country
            12.2.1.1. Germany
            12.2.1.2. UK
            12.2.1.3. France
            12.2.1.4. Spain
            12.2.1.5. Italy
            12.2.1.6. Rest of Western Europe
        12.2.2. By Type
        12.2.3. By Animal Type
        12.2.4. By Route of Administration
        12.2.5. By Distribution Channel
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Type
        12.3.3. By Animal Type
        12.3.4. By Route of Administration
        12.3.5. By Distribution Channel
    12.4. Key Takeaways
13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    13.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        13.2.1. By Country
            13.2.1.1. Poland
            13.2.1.2. Russia
            13.2.1.3. Czech Republic
            13.2.1.4. Romania
            13.2.1.5. Rest of Eastern Europe
        13.2.2. By Type
        13.2.3. By Animal Type
        13.2.4. By Route of Administration
        13.2.5. By Distribution Channel
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Type
        13.3.3. By Animal Type
        13.3.4. By Route of Administration
        13.3.5. By Distribution Channel
    13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    14.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        14.2.1. By Country
            14.2.1.1. India
            14.2.1.2. Bangladesh
            14.2.1.3. Australia
            14.2.1.4. New Zealand
            14.2.1.5. Rest of South Asia and Pacific
        14.2.2. By Type
        14.2.3. By Animal Type
        14.2.4. By Route of Administration
        14.2.5. By Distribution Channel
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Type
        14.3.3. By Animal Type
        14.3.4. By Route of Administration
        14.3.5. By Distribution Channel
    14.4. Key Takeaways
15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    15.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    15.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        15.2.1. By Country
            15.2.1.1. China
            15.2.1.2. Japan
            15.2.1.3. South Korea
        15.2.2. By Type
        15.2.3. By Animal Type
        15.2.4. By Route of Administration
        15.2.5. By Distribution Channel
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Type
        15.3.3. By Animal Type
        15.3.4. By Route of Administration
        15.3.5. By Distribution Channel
    15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    16.1. Historical Market Size Value (US$ Million) & Volume (Vials) Trend Analysis By Market Taxonomy, 2019 to 2023
    16.2. Market Size Value (US$ Million) & Volume (Vials) Forecast By Market Taxonomy, 2024 to 2034
        16.2.1. By Country
            16.2.1.1. GCC Countries
            16.2.1.2. South Africa
            16.2.1.3. Israel
            16.2.1.4. Rest of MEA
        16.2.2. By Type
        16.2.3. By Animal Type
        16.2.4. By Route of Administration
        16.2.5. By Distribution Channel
    16.3. Market Attractiveness Analysis
        16.3.1. By Country
        16.3.2. By Type
        16.3.3. By Animal Type
        16.3.4. By Route of Administration
        16.3.5. By Distribution Channel
    16.4. Key Takeaways
17. Key Countries Market Analysis
    17.1. USA
        17.1.1. Pricing Analysis
        17.1.2. Market Share Analysis, 2023
            17.1.2.1. By Type
            17.1.2.2. By Animal Type
            17.1.2.3. By Route of Administration
            17.1.2.4. By Distribution Channel
    17.2. Canada
        17.2.1. Pricing Analysis
        17.2.2. Market Share Analysis, 2023
            17.2.2.1. By Type
            17.2.2.2. By Animal Type
            17.2.2.3. By Route of Administration
            17.2.2.4. By Distribution Channel
    17.3. Brazil
        17.3.1. Pricing Analysis
        17.3.2. Market Share Analysis, 2023
            17.3.2.1. By Type
            17.3.2.2. By Animal Type
            17.3.2.3. By Route of Administration
            17.3.2.4. By Distribution Channel
    17.4. Mexico
        17.4.1. Pricing Analysis
        17.4.2. Market Share Analysis, 2023
            17.4.2.1. By Type
            17.4.2.2. By Animal Type
            17.4.2.3. By Route of Administration
            17.4.2.4. By Distribution Channel
    17.5. Germany
        17.5.1. Pricing Analysis
        17.5.2. Market Share Analysis, 2023
            17.5.2.1. By Type
            17.5.2.2. By Animal Type
            17.5.2.3. By Route of Administration
            17.5.2.4. By Distribution Channel
    17.6. UK
        17.6.1. Pricing Analysis
        17.6.2. Market Share Analysis, 2023
            17.6.2.1. By Type
            17.6.2.2. By Animal Type
            17.6.2.3. By Route of Administration
            17.6.2.4. By Distribution Channel
    17.7. France
        17.7.1. Pricing Analysis
        17.7.2. Market Share Analysis, 2023
            17.7.2.1. By Type
            17.7.2.2. By Animal Type
            17.7.2.3. By Route of Administration
            17.7.2.4. By Distribution Channel
    17.8. Spain
        17.8.1. Pricing Analysis
        17.8.2. Market Share Analysis, 2023
            17.8.2.1. By Type
            17.8.2.2. By Animal Type
            17.8.2.3. By Route of Administration
            17.8.2.4. By Distribution Channel
    17.9. Italy
        17.9.1. Pricing Analysis
        17.9.2. Market Share Analysis, 2023
            17.9.2.1. By Type
            17.9.2.2. By Animal Type
            17.9.2.3. By Route of Administration
            17.9.2.4. By Distribution Channel
    17.10. Poland
        17.10.1. Pricing Analysis
        17.10.2. Market Share Analysis, 2023
            17.10.2.1. By Type
            17.10.2.2. By Animal Type
            17.10.2.3. By Route of Administration
            17.10.2.4. By Distribution Channel
    17.11. Russia
        17.11.1. Pricing Analysis
        17.11.2. Market Share Analysis, 2023
            17.11.2.1. By Type
            17.11.2.2. By Animal Type
            17.11.2.3. By Route of Administration
            17.11.2.4. By Distribution Channel
    17.12. Czech Republic
        17.12.1. Pricing Analysis
        17.12.2. Market Share Analysis, 2023
            17.12.2.1. By Type
            17.12.2.2. By Animal Type
            17.12.2.3. By Route of Administration
            17.12.2.4. By Distribution Channel
    17.13. Romania
        17.13.1. Pricing Analysis
        17.13.2. Market Share Analysis, 2023
            17.13.2.1. By Type
            17.13.2.2. By Animal Type
            17.13.2.3. By Route of Administration
            17.13.2.4. By Distribution Channel
    17.14. India
        17.14.1. Pricing Analysis
        17.14.2. Market Share Analysis, 2023
            17.14.2.1. By Type
            17.14.2.2. By Animal Type
            17.14.2.3. By Route of Administration
            17.14.2.4. By Distribution Channel
    17.15. Bangladesh
        17.15.1. Pricing Analysis
        17.15.2. Market Share Analysis, 2023
            17.15.2.1. By Type
            17.15.2.2. By Animal Type
            17.15.2.3. By Route of Administration
            17.15.2.4. By Distribution Channel
    17.16. Australia
        17.16.1. Pricing Analysis
        17.16.2. Market Share Analysis, 2023
            17.16.2.1. By Type
            17.16.2.2. By Animal Type
            17.16.2.3. By Route of Administration
            17.16.2.4. By Distribution Channel
    17.17. New Zealand
        17.17.1. Pricing Analysis
        17.17.2. Market Share Analysis, 2023
            17.17.2.1. By Type
            17.17.2.2. By Animal Type
            17.17.2.3. By Route of Administration
            17.17.2.4. By Distribution Channel
    17.18. China
        17.18.1. Pricing Analysis
        17.18.2. Market Share Analysis, 2023
            17.18.2.1. By Type
            17.18.2.2. By Animal Type
            17.18.2.3. By Route of Administration
            17.18.2.4. By Distribution Channel
    17.19. Japan
        17.19.1. Pricing Analysis
        17.19.2. Market Share Analysis, 2023
            17.19.2.1. By Type
            17.19.2.2. By Animal Type
            17.19.2.3. By Route of Administration
            17.19.2.4. By Distribution Channel
    17.20. South Korea
        17.20.1. Pricing Analysis
        17.20.2. Market Share Analysis, 2023
            17.20.2.1. By Type
            17.20.2.2. By Animal Type
            17.20.2.3. By Route of Administration
            17.20.2.4. By Distribution Channel
    17.21. GCC Countries
        17.21.1. Pricing Analysis
        17.21.2. Market Share Analysis, 2023
            17.21.2.1. By Type
            17.21.2.2. By Animal Type
            17.21.2.3. By Route of Administration
            17.21.2.4. By Distribution Channel
    17.22. South Africa
        17.22.1. Pricing Analysis
        17.22.2. Market Share Analysis, 2023
            17.22.2.1. By Type
            17.22.2.2. By Animal Type
            17.22.2.3. By Route of Administration
            17.22.2.4. By Distribution Channel
    17.23. Israel
        17.23.1. Pricing Analysis
        17.23.2. Market Share Analysis, 2023
            17.23.2.1. By Type
            17.23.2.2. By Animal Type
            17.23.2.3. By Route of Administration
            17.23.2.4. By Distribution Channel
18. Market Structure Analysis
    18.1. Competition Dashboard
    18.2. Competition Benchmarking
    18.3. Market Share Analysis of Top Players
        18.3.1. By Regional
        18.3.2. By Type
        18.3.3. By Animal Type
        18.3.4. By Route of Administration
        18.3.5. By Distribution Channel
19. Competition Analysis
    19.1. Competition Deep Dive
        19.1.1. Boehringer Ingelheim International GmbH
            19.1.1.1. Overview
            19.1.1.2. Product Portfolio
            19.1.1.3. Profitability by Market Segments
            19.1.1.4. Sales Footprint
            19.1.1.5. Strategy Overview
                19.1.1.5.1. Marketing Strategy
                19.1.1.5.2. Product Strategy
                19.1.1.5.3. Channel Strategy
        19.1.2. Virbac
            19.1.2.1. Overview
            19.1.2.2. Product Portfolio
            19.1.2.3. Profitability by Market Segments
            19.1.2.4. Sales Footprint
            19.1.2.5. Strategy Overview
                19.1.2.5.1. Marketing Strategy
                19.1.2.5.2. Product Strategy
                19.1.2.5.3. Channel Strategy
        19.1.3. Merck Animal Health (Merck & Co., Inc.)
            19.1.3.1. Overview
            19.1.3.2. Product Portfolio
            19.1.3.3. Profitability by Market Segments
            19.1.3.4. Sales Footprint
            19.1.3.5. Strategy Overview
                19.1.3.5.1. Marketing Strategy
                19.1.3.5.2. Product Strategy
                19.1.3.5.3. Channel Strategy
        19.1.4. Zoetis Services LLC
            19.1.4.1. Overview
            19.1.4.2. Product Portfolio
            19.1.4.3. Profitability by Market Segments
            19.1.4.4. Sales Footprint
            19.1.4.5. Strategy Overview
                19.1.4.5.1. Marketing Strategy
                19.1.4.5.2. Product Strategy
                19.1.4.5.3. Channel Strategy
        19.1.5. Ceva
            19.1.5.1. Overview
            19.1.5.2. Product Portfolio
            19.1.5.3. Profitability by Market Segments
            19.1.5.4. Sales Footprint
            19.1.5.5. Strategy Overview
                19.1.5.5.1. Marketing Strategy
                19.1.5.5.2. Product Strategy
                19.1.5.5.3. Channel Strategy
        19.1.6. Elanco
            19.1.6.1. Overview
            19.1.6.2. Product Portfolio
            19.1.6.3. Profitability by Market Segments
            19.1.6.4. Sales Footprint
            19.1.6.5. Strategy Overview
                19.1.6.5.1. Marketing Strategy
                19.1.6.5.2. Product Strategy
                19.1.6.5.3. Channel Strategy
        19.1.7. HIPRA
            19.1.7.1. Overview
            19.1.7.2. Product Portfolio
            19.1.7.3. Profitability by Market Segments
            19.1.7.4. Sales Footprint
            19.1.7.5. Strategy Overview
                19.1.7.5.1. Marketing Strategy
                19.1.7.5.2. Product Strategy
                19.1.7.5.3. Channel Strategy
        19.1.8. Neogen Corporation
            19.1.8.1. Overview
            19.1.8.2. Product Portfolio
            19.1.8.3. Profitability by Market Segments
            19.1.8.4. Sales Footprint
            19.1.8.5. Strategy Overview
                19.1.8.5.1. Marketing Strategy
                19.1.8.5.2. Product Strategy
                19.1.8.5.3. Channel Strategy
        19.1.9. Dechra Pharmaceuticals PLC
            19.1.9.1. Overview
            19.1.9.2. Product Portfolio
            19.1.9.3. Profitability by Market Segments
            19.1.9.4. Sales Footprint
            19.1.9.5. Strategy Overview
                19.1.9.5.1. Marketing Strategy
                19.1.9.5.2. Product Strategy
                19.1.9.5.3. Channel Strategy
        19.1.10. Biogénesis Bagó
            19.1.10.1. Overview
            19.1.10.2. Product Portfolio
            19.1.10.3. Profitability by Market Segments
            19.1.10.4. Sales Footprint
            19.1.10.5. Strategy Overview
                19.1.10.5.1. Marketing Strategy
                19.1.10.5.2. Product Strategy
                19.1.10.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Recommendations

Healthcare

Vaccines Market

January 2023

REP-GB-14284

320 pages

Healthcare

Seasonal Influenza Vaccines Therapeutics Market

December 2022

REP-GB-2498

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Live Stock Vaccine Market

Schedule a Call